DARE stock

Dare Bioscience Inc (DARE) earnings · rev $1.0M

These earnings events as JSON? API free 100/day

Dare Bioscience Inc (DARE) is a biotechnology company listed on US.

This DARE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was down 63.3% from 2023-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.

When the next DARE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was down 63.3% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full DARE research stays on the stock page; the tape stays on the quote page.

DARE earnings FAQ

What are DARE's latest revenue and net income?

Latest cached Dare Bioscience Inc (DARE) revenue for Dec 31, 2025 was $1.0M. Net income was -$13.4M. Statements: https://lician.com/financials/dare

What is DARE's latest diluted EPS?

Latest cached Dare Bioscience Inc (DARE) diluted EPS for Dec 31, 2025 was -$1.20.

What period does the latest DARE earnings print cover?

The latest cached Dare Bioscience Inc (DARE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.

How did DARE revenue change from the prior cached period?

Cached Dare Bioscience Inc (DARE) revenue was down 63.3% from $2.8M (Dec 31, 2023) to $1.0M (Dec 31, 2025). Statements: https://lician.com/financials/dare

Where are DARE earnings listed?

Cached earnings facts for Dare Bioscience Inc (DARE) are listed at https://lician.com/earnings/dare. Statements: https://lician.com/financials/dare

Not investment advice.

Full DARE analysis